{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:15:55Z","timestamp":1783091755178,"version":"3.54.6"},"reference-count":86,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2020,8,17]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>The interlink between diabetes mellitus and neurodegenerative diseases such as Alzheimer\u2019s\nDisease (AD) and Parkinson\u2019s Disease (PD) has been identified by several researchers. Patients\nwith Type-2 Diabetes Mellitus (T2DM) are found to be affected with cognitive impairments\nleading to learning and memory deficit, while patients with Type-1 Diabetes Mellitus (T1DM) showed\nless severe levels of these impairments in the brain. This review aimed to discuss the connection between\ninsulin with the pathophysiology of neurodegenerative diseases (AD and PD) and the current\ntherapeutic approached mediated through insulin for management of neurodegenerative diseases. An\nextensive literature search was conducted using keywords \u201cinsulin\u201d; \u201cinsulin resistance\u201d; \u201cAlzheimer\u2019s\ndisease\u201d; \u201cParkinson\u2019s disease\u201d in public domains of Google scholar, PubMed, and ScienceDirect.\nSelected articles were used to construct this review. Studies have shown that impaired insulin\nsignaling contributes to the accumulation of amyloid-&amp;#946;, neurofibrillary tangles, tau proteins and\n&amp;#945;-synuclein in the brain. Whereas, improvement in insulin signaling slows down the progression of\ncognitive decline. Various therapeutic approaches for altering the insulin function in the brain have\nbeen researched. Besides intranasal insulin, other therapeutics like PPAR-&amp;#947; agonists, neurotrophins,\nstem cell therapy and insulin-like growth factor-1 are under investigation. Research has shown that insulin\ninsensitivity in T2DM leads to neurodegeneration through mechanisms involving a variety of extracellular,\nmembrane receptor, and intracellular signaling pathway disruptions. Some therapeutics,\nsuch as intranasal administration of insulin and neuroactive substances have shown promise but face\nproblems related to genetic background, accessibility to the brain, and invasiveness of the procedures.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871527319666200518102130","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T08:16:00Z","timestamp":1589789760000},"page":"174-183","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Interlink Between Insulin Resistance and Neurodegeneration with an Update on Current Therapeutic Approaches"],"prefix":"10.2174","volume":"19","author":[{"given":"Subrat Kumar","family":"Bhattamisra","sequence":"first","affiliation":[{"name":"Department of Life Sciences, School of Pharmacy, International Medical University, No. 126, Jalan Jalil Perkasa 19, Bukit Jalil 57000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee Yuen","family":"Shin","sequence":"additional","affiliation":[{"name":"School of Health Sciences, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanis Izzati Binti Mohd","family":"Saad","sequence":"additional","affiliation":[{"name":"School of Health Sciences, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Rao","sequence":"additional","affiliation":[{"name":"School of Postgraduate Studies, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuren","family":"Candasamy","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, School of Pharmacy, International Medical University, No. 126, Jalan Jalil Perkasa 19, Bukit Jalil 57000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira","family":"Choudhury","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","author":"Morris,JK.","unstructured":"Morris,JK.; Burns,JM. Insulin: an emerging treatment for Alz-heimer\u2019s disease dementia? Curr Neurol Neurosci Rep. 2012; 12(5): 520-7. http:\/\/dx.doi.org\/10.1007\/s11910-012-0297-0 PMID: 22791280","DOI":"10.1007\/s11910-012-0297-0"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"18543","DOI":"10.1074\/jbc.M414112200","volume":"280(18)","author":"Lee,CC.","year":"2005","unstructured":"Lee,CC.; Huang,CC.; Wu,MY.; Hsu,KS. Insulin stimulates postsyn-aptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway. J Biol Chem. 2005; 280(18): 18543-50. http:\/\/dx.doi.org\/10.1074\/jbc.M414112200 PMID: 15755733","journal-title":"J Biol Chem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0031-9384(99) 00220-6","volume":"68(4)","author":"Park,CR.","year":"2000","unstructured":"Park,CR.; Seeley,RJ.; Craft,S.; Woods,SC. Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Be-hav. 2000; 68(4): 509-14. http:\/\/dx.doi.org\/10.1016\/S0031-9384(99) 00220-6 PMID: 10713291","journal-title":"Physiol Be-hav"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2174\/1871527317666181114163515","volume":"18(3)","author":"Gupta,S.","year":"2019","unstructured":"Gupta,S.; Singhal,NK.; Ganesh,S.; Sa,ndhir,R. Extending arms of insulin resistance from diabetes to Alzheimer\u2019s disease: identifica-tion of potential therapeutic targets. CNS Neurol Disord Drug Tar-gets. 2019; 18(3): 172-84. http:\/\/dx.doi.org\/10.2174\/1871527317666181114163515 PMID: 30430949","journal-title":"CNS Neurol Disord Drug Tar-gets"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1210\/mend-4-5-773","volume":"4(5)","author":"Werther,GA.","year":"1990","unstructured":"Werther GA, Abate M, Hogg A.;et al. Localization of insulin-like growth factor-I mRNA in rat brain by in situ hybridization--relationship to IGF-I receptors. Mol Endocrinol. 1990; 4(5): 773-8. http:\/\/dx.doi.org\/10.1210\/mend-4-5-773 PMID: 2177145","journal-title":"Mol Endocrinol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fnins.2018.00073","volume":"12","author":"Yang,L.","year":"2018","unstructured":"Yang,L.; Wang,H.; Liu,L.; Xie,A. The role of insulin\/IGF-1\/PI3K\/Akt\/GSK3\u00df signaling in Parkinson\u2019s disease dementia. Front Neurosci. 2018; 12: 73. http:\/\/dx.doi.org\/10.3389\/fnins.2018.00073 PMID: 29515352","journal-title":"Front Neurosci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1152\/jn.2000.83.4.2332","volume":"83(4)","author":"Fadool,DA.","year":"2000","unstructured":"Fadool,DA.; Tucker,K.; Phillips,JJ.; Simmen,JA. Brain insulin recep-tor causes activity-dependent current suppression in the olfactory bulb through multiple phosphorylation of Kv1.3. J Neurophysiol. 2000; 83(4): 2332-48. http:\/\/dx.doi.org\/10.1152\/jn.2000.83.4.2332 PMID: 10758137","journal-title":"J Neurophysiol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1254\/jphs.CRJ05006X","volume":"99(2)","author":"Wada,A.","year":"2005","unstructured":"Wada,A.; Yokoo,H.; Yanagita,T.; Kobayashi,H. New twist on neu-ronal insulin receptor signaling in health, disease, and therapeutics. J Pharmacol Sci. 2005; 99(2): 128-43. http:\/\/dx.doi.org\/10.1254\/jphs.CRJ05006X PMID: 16210778","journal-title":"J Pharmacol Sci"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2174\/1871527317666180724143258","volume":"17(8)","author":"Arshad,N.","year":"2018","unstructured":"Arshad,N.; Lin,TS.; Yahaya,MF. Metabolic syndrome and its effect on the brain: possible mechanism. CNS Neurol Disord Drug Tar-gets. 2018; 17(8): 595-603. PMID: 30047340","journal-title":"CNS Neurol Disord Drug Tar-gets"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1212\/WNL.50.1.164","volume":"50(1)","author":"Craft,S.","year":"1998","unstructured":"Craft,S.; Peskind,E.; Schwartz,MW.; Schellenberg,GD.; Raskind,M.; Porte,D,Jr. Cerebrospinal fluid and plasma insulin levels in Alz-heimer\u2019s disease: relationship to severity of dementia and apolipo-protein E genotype. Neurology. 1998; 50(1): 164-8. http:\/\/dx.doi.org\/10.1212\/WNL.50.1.164 PMID: 9443474","journal-title":"Neurology"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/156720512799015037","volume":"9(1)","author":"de la Monte SM","year":"2012","unstructured":"de la Monte SM. Brain insulin resistance and deficiency as thera-peutic targets in Alzheimer\u2019s disease. Curr Alzheimer Res. 2012; 9(1): 35-66. http:\/\/dx.doi.org\/10.2174\/156720512799015037 PMID: 22329651","journal-title":"Curr Alzheimer Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1093\/brain\/awv104","volume":"138(Pt 6)","author":"Gratwicke,J.","year":"2015","unstructured":"Gratwicke,J.; Jahanshahi,M.; Foltynie,T. Parkinson\u2019s disease demen-tia: a neural networks perspective. Brain. 2015; 138(Pt 6): 1454-76. http:\/\/dx.doi.org\/10.1093\/brain\/awv104 PMID: 25888551","journal-title":"Brain"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"985845","DOI":"10.1155\/2015\/985845","volume":"2015","author":"Rosales-Corral,S.","year":"2015","unstructured":"Rosales-Corral,S.; Tan,DX.; Manchester,L.; Reiter,RJ. Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress. Oxid Med Cell Longev. 2015; 2015: 985845. http:\/\/dx.doi.org\/10.1155\/2015\/985845 PMID: 25815110","journal-title":"Oxid Med Cell Longev"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","volume":"31(2)","author":"Moloney,AM.","year":"2010","unstructured":"Moloney,AM.; Griffin,RJ.; Timmons,S.; O\u2019Connor,R.; Ravid,R.; O\u2019Neill,C. Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and in-sulin signalling. Neurobiol Aging. 2010; 31(2): 224-43. http:\/\/dx.doi.org\/10.1016\/j.neurobiolaging.2008.04.002 PMID: 18479783","journal-title":"Neurobiol Aging"},{"key":"ref=15","doi-asserted-by":"publisher","author":"Hlscher,C.","unstructured":"H\u00f6lscher,C.; Li,L. New roles for insulin-like hormones in neuronal signalling and protection: new hopes for novel treatments of Alz-heimer\u2019s disease? Neurobiol Aging. 2010; 31(9): 1495-502. http:\/\/dx.doi.org\/10.1016\/j.neurobiolaging.2008.08.023 PMID: 18930564","DOI":"10.1016\/j.neurobiolaging.2008.08.023"},{"key":"ref=16","doi-asserted-by":"publisher","author":"Correia,SC.","unstructured":"Correia,SC.; Santos,RX.; Perry,G.; Zhu,X.; Moreira,PI.; Smith,MA. Insulin-resistant brain state: the culprit in sporadic Alzheimer\u2019s dis-ease? Ageing Res Rev. 2011; 10(2): 264-73. http:\/\/dx.doi.org\/10.1016\/j.arr.2011.01.001 PMID: 21262392","DOI":"10.1016\/j.arr.2011.01.001"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/archneurol.2010.225","volume":"68(1)","author":"Baker,LD.","year":"2011","unstructured":"Baker,LD.; Cross,DJ.; Minoshima,S.; Belongia,D.; Watson,GS.; Craft,S. Insulin resistance and Alzheimer-like reductions in regional cer-ebral glucose metabolism for cognitively normal adults with predi-abetes or early type 2 diabetes. Arch Neurol. 2011; 68(1): 51-7. http:\/\/dx.doi.org\/10.1001\/archneurol.2010.225 PMID: 20837822","journal-title":"Arch Neurol"},{"key":"ref=18","author":"Benedict,C.","unstructured":"Benedict C, Brooks SJ, Kullberg J.;et al. Impaired insulin sensitivi-ty as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter. ume in the elderly. Diabetes Care. 2012; 35(3): 488-94. http:\/\/dx.doi.org\/10.2337\/dc11-2075 PMID: 22301128","journal-title":"ume in the elderly"},{"key":"ref=19","author":"Tan,ZS.","unstructured":"Tan ZS, Beiser AS, Fox CS.;et al. Association of metabolic dysregulation with. umetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study. Diabetes Care. 2011; 34(8): 1766-70. http:\/\/dx.doi.org\/10.2337\/dc11-0308 PMID: 21680719"},{"key":"ref=20","doi-asserted-by":"publisher","author":"Athauda,D.","unstructured":"Athauda,D.; Foltynie,T. Insulin resistance and Parkinson\u2019s disease: a new target for disease modifica tion? Prog Neurobiol. 2016; 145-146: 98-120. http:\/\/dx.doi.org\/10.1016\/j.pneurobio.2016.10.001 PMID: 27713036","DOI":"10.1016\/j.pneurobio.2016.10.001"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"38187","DOI":"10.1038\/srep38187","volume":"6","author":"Esparza,TJ.","year":"2016","unstructured":"Esparza TJ, Wildburger NC, Jiang H.;et al. Soluble amyloid-beta aggregates from human Alzheimer\u2019s disease brains. Sci Rep. 2016; 6: 38187. http:\/\/dx.doi.org\/10.1038\/srep38187 PMID: 27917876","journal-title":"Sci Rep"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature11060","volume":"485(7400)","author":"Nussbaum,JM.","year":"2012","unstructured":"Nussbaum JM, Schilling S, Cynis H.;et al. Prion-like behaviour and tau-dependent cytotoxicity of pyr oglutamylated amyloid-\u00df. Nature. 2012; 485(7400): 651-5. http:\/\/dx.doi.org\/10.1038\/nature11060 PMID: 22660329","journal-title":"Nature"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.exger.2014.10.002","volume":"68","author":"Ashpole,NM.","year":"2015","unstructured":"Ashpole,NM.; Sanders,JE.; Hodges,EL.; Yan,H.; Sonntag,WE. Growth hormone, insulin-like growth factor-1 and the aging brain. Exp Gerontol. 2015; 68: 76-81. http:\/\/dx.doi.org\/10.1016\/j.exger.2014.10.002 PMID: 25300732","journal-title":"Exp Gerontol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.2337\/dbi15-0011","volume":"64(11)","author":"De,Felice,FG.;,Benedict,C","year":"2015","unstructured":"De Felice,FG.; Benedict,C. A key role of insulin receptors in memory. Diabetes. 2015; 64(11): 3653-5. http:\/\/dx.doi.org\/10.2337\/dbi15-0011 PMID: 26494219","journal-title":"Diabetes"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.nlm.2010.02.002","volume":"93(4)","author":"McNay,EC.","year":"2010","unstructured":"McNay,EC.; Ong,CT.; McCrimmon,RJ.; Cresswell,J.; Bogan,JS.; Sherwin,RS. Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem. 2010; 93(4): 546-53. http:\/\/dx.doi.org\/10.1016\/j.nlm.2010.02.002 PMID: 20176121","journal-title":"Neurobiol Learn Mem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","volume":"14","author":"Cheignon,C.","year":"2018","unstructured":"Cheignon,C.; Tomas,M.; Bonnefont-Rousselot,D.; Faller,P.; Hureau,C.; Collin,F. Oxidative stress and the amyloid beta peptide in Alz-heimer\u2019s disease. Redox Biol. 2018; 14: 450-64. http:\/\/dx.doi.org\/10.1016\/j.redox.2017.10.014 PMID: 29080524","journal-title":"Redox Biol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/193229680800200619","volume":"2(6)","author":"de,la Monte,SM.","year":"2008","unstructured":"de,la Monte,SM.; Wands,JR. Alzheimer\u2019s disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol. 2008; 2(6): 1101-13. http:\/\/dx.doi.org\/10.1177\/193229680800200619 PMID: 19885299","journal-title":"J Diabetes Sci Technol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.bbadis.2014.06.010","volume":"1842(9)","author":"Butterfield,DA.","year":"2014","unstructured":"Butterfield,DA.; Di Domenico,F.; Bar,one,E. Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxi-dative stress in brain. Biochim Biophys Acta. 2014; 1842(9): 1693-706. http:\/\/dx.doi.org\/10.1016\/j.bbadis.2014.06.010 PMID: 24949886","journal-title":"Biochim Biophys Acta"},{"key":"ref=29","author":"Candasamy,M.","unstructured":"Candasamy M, Elhassan SA, Bhattamisra SK.;et al. Type 3 diabe-tes (Alzheimer\u2019s disease): new insight for promising therapeutic avenues. Panminerva Med 2020. http:\/\/dx.doi.org\/10.23736\/s0031-0808.20.03879-3 PMID: 32208408","journal-title":"Panminerva Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122(4)","author":"Talbot,K.","year":"2012","unstructured":"Talbot K, Wang HY, Kazi H.;et al. Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012; 122(4): 1316-38. http:\/\/dx.doi.org\/10.1172\/JCI59903 PMID: 22476197","journal-title":"J Clin Invest"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fnins.2015.00204","volume":"9","author":"Bedse,G.","year":"2015","unstructured":"Bedse,G.; Di Domenico,F.; Serviddi,o,G.; Cassano,T. Aberrant insu-lin signaling in Alzheimer\u2019s disease: current knowledge. Front Neurosci. 2015; 9: 204. http:\/\/dx.doi.org\/10.3389\/fnins.2015.00204 PMID: 26136647","journal-title":"Front Neurosci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fendo.2014.00161","volume":"5","author":"Bl\u00e1zquez,E.","year":"2014","unstructured":"Bl\u00e1zquez,E.; Vel\u00e1zquez,E.; Hurtado-Carneiro,V.; Ruiz-Albusac,JM. Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alz-heimer\u2019s disease. Front Endocrinol (Lausanne). 2014; 5: 161. http:\/\/dx.doi.org\/10.3389\/fendo.2014.00161 PMID: 25346723","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2005.01.004","volume":"27(2)","author":"Qiu,WQ.","year":"2006","unstructured":"Qiu,WQ.; Folstein,MF. Insulin, insulin-degrading enzyme and amyloid-\u00df peptide in Alzheimer\u2019s disease: review and hypothesis. Neurobiol Aging. 2006; 27(2): 190-8. http:\/\/dx.doi.org\/10.1016\/j.neurobiolaging.2005.01.004 PMID: 16399206","journal-title":"Neurobiol Aging"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2174\/1871527318666191011145941","volume":"18(9)","author":"Ahmad,SS.","year":"2019","unstructured":"Ahmad,SS.; Khan,S.; Kamal,MA.; Wasi,U. The structure and func-tion of a, \u00df and ?-secretase as therapeutic target enzymes in the de-velopment of Alzheimer\u2019s disease: A review. CNS Neurol Disord Drug Targets. 2019; 18(9): 657-67. http:\/\/dx.doi.org\/10.2174\/1871527318666191011145941 PMID: 31608840","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3233\/JAD-2009-1155","volume":"18(3)","author":"Cardoso,S.","year":"2009","unstructured":"Cardoso S, Correia S, Santos RX.;et al. Insulin is a two-edged knife on the brain. J Alzheimers Dis. 2009; 18(3): 483-507. http:\/\/dx.doi.org\/10.3233\/JAD-2009-1155 PMID: 19542630","journal-title":"J Alzheimers Dis"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00401-014-1328-5","volume":"128(5)","author":"Yarchoan,M.","year":"2014","unstructured":"Yarchoan M, Toledo JB, Lee EB.;et al. Abnormal serine phosphor-ylation of insulin receptor substrate 1 is associated with tau pathol-ogy in Alzheimer\u2019s disease and tauopathies. Acta Neuropathol. 2014; 128(5): 679-89. http:\/\/dx.doi.org\/10.1007\/s00401-014-1328-5 PMID: 25107476","journal-title":"Acta Neuropathol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.bbadis.2014.04.007","volume":"1842(7)","author":"Perluigi,M.","year":"2014","unstructured":"Perluigi M, Pupo G, Tramutola A.;et al. Neuropathological role of PI3K\/Akt\/mTOR axis in Down syndrome brain. Biochim Biophys Acta. 2014; 1842(7): 1144-53. http:\/\/dx.doi.org\/10.1016\/j.bbadis.2014.04.007 PMID: 24735980","journal-title":"Biochim Biophys Acta"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s10495-010-0463-2","volume":"15(11)","author":"Rohn,TT","year":"2010","unstructured":"Rohn TT. The role of caspases in Alzheimer\u2019s disease; potential novel therapeutic opportunities. Apoptosis. 2010; 15(11): 1403-9. http:\/\/dx.doi.org\/10.1007\/s10495-010-0463-2 PMID: 20127416","journal-title":"Apoptosis"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.toxlet.2016.01.007","volume":"245","author":"Fang,F.","year":"2016","unstructured":"Fang F, Gao Y, Wang T.;et al. Insulin signaling disruption in male mice due to perinatal bisphenol A exposure: Role of insulin signal-ing in the brain. Toxicol Lett. 2016; 245: 59-67. http:\/\/dx.doi.org\/10.1016\/j.toxlet.2016.01.007 PMID: 26779933","journal-title":"Toxicol Lett"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2011.12.008","volume":"315(1-2)","author":"Bosco,D.","year":"2012","unstructured":"Bosco D, Plastino M, Cristiano D.;et al. Dementia is associated with insulin resistance in patient s with Parkinson\u2019s disease. J Neu-rol Sci. 2012; 315(1-2): 39-43. http:\/\/dx.doi.org\/10.1016\/j.jns.2011.12.008 PMID: 22265943","journal-title":"J Neu-rol Sci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.toxlet.2014.11.029","volume":"233(2)","author":"Yuan,YH.","year":"2015","unstructured":"Yuan,YH.; Yan,WF.; Sun,JD.; Huang,JY.; Mu,Z.; Chen,NH. The molecular mechanism of rotenone-induced a-synuclein aggrega-tion: emphasizing the role of th e calcium\/GSK3\u00df pathway. Toxicol Lett. 2015; 233(2): 163-71. http:\/\/dx.doi.org\/10.1016\/j.toxlet.2014.11.029 PMID: 25433145","journal-title":"Toxicol Lett"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2174\/1871527317666180816095707","volume":"18(2)","author":"Askar,MH.","year":"2019","unstructured":"Askar MH, Hussein AM, Al-Basiony SF.;et al. Effects of exercise and ferulic acid on alpha synuclein and neuroprotective heat shock protein 70 in an experimental model of Parkinsonism disease. CNS Neurol Disord Drug Targets. 2019; 18(2): 156-69. http:\/\/dx.doi.org\/10.2174\/1871527317666180816095707 PMID: 30113007","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12640-012-9330-y","volume":"23(1)","author":"Majd,S.","year":"2013","unstructured":"Majd,S.; Chegini,F.; Chataway,T.; Zhou,XF.; Gai,W. Reciprocal induction between a-synuclein and \u00df-amyloid in adult rat neurons. Neurotox Res. 2013; 23(1): 69-78. http:\/\/dx.doi.org\/10.1007\/s12640-012-9330-y PMID: 22610785","journal-title":"Neurotox Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2174\/1871527317666180816100203","volume":"17(9)","author":"Kumar,A.","year":"2018","unstructured":"Kumar,A.; Dhawan,A.; Kadam,A.; Shinde,A. Autophagy and mito-chondria: targets in neurodegenerative disorders. CNS Neurol Dis-ord Drug Targets. 2018; 17(9): 696-705. http:\/\/dx.doi.org\/10.2174\/1871527317666180816100203 PMID: 30113005","journal-title":"CNS Neurol Dis-ord Drug Targets"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"e94259","DOI":"10.1371\/journal.pone.0094259","volume":"9(4)","author":"Gassowska,M.","year":"2014","unstructured":"Gassowska,M.; Czapski,GA.; Pajak,B.; Cieslik,M.; Lenkiewicz,AM.; Adamczyk,A. Extracellular a-synuclein leads to microtubule desta-bilization via GSK-3\u00df-dependent Tau phosphorylation in PC12 cells. PLoS One. 2014; 9(4): e94259. http:\/\/dx.doi.org\/10.1371\/journal.pone.0094259 PMID: 24722055","journal-title":"PLoS One"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"12531","DOI":"10.1038\/srep12531","volume":"5","author":"Sharma,SK.","year":"2015","unstructured":"Sharma,SK.; Chorell,E.; Steneberg,P.; Vernersson-Lindahl,E.; Edlund,H.; Wittung-Stafshede,P. Insulin-degrading enzyme prevents a-synuclein fibril formation in a nonproteolytical manner. Sci Rep. 2015; 5: 12531. http:\/\/dx.doi.org\/10.1038\/srep12531 PMID: 26228656","journal-title":"Sci Rep"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/dneu.20609","volume":"68(5)","author":"Quesada,A.","year":"2008","unstructured":"Quesada,A.; Lee,BYMP.; Micevych,PE. PI3 kinase\/Akt activation mediates estrogen and IGF-1 nigr al DA neuronal neuroprotection against a unilateral rat model of Parkinson\u2019s disease. Dev Neurobi-ol. 2008; 68(5): 632-44. http:\/\/dx.doi.org\/10.1002\/dneu.20609 PMID: 18278798","journal-title":"Dev Neurobi-ol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1007\/s00125-009-1338-3","volume":"52(6)","author":"Lee,CC.","year":"2009","unstructured":"Lee CC, Adler AI, Sandhu MS.;et al. Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. Diabetologia. 2009; 52(6): 1040-7. http:\/\/dx.doi.org\/10.1007\/s00125-009-1338-3 PMID: 19326095","journal-title":"Diabetologia"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"680","DOI":"10.2174\/1871527317666180625104753","volume":"17(9)","author":"Pandareesh,MD.","year":"2018","unstructured":"Pandareesh MD, Kandikattu HK, Razack S.;et al. Nutrition and nutraceuticals in neuroinflammatory and brain metabolic stress: implications for neurodegenerative disorders. CNS Neurol Disord Drug Targets. 2018; 17(9): 680-8. http:\/\/dx.doi.org\/10.2174\/1871527317666180625104753 PMID: 29938622","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"e0172429","DOI":"10.1371\/journal.pone.0172429","volume":"12(5)","author":"Balbaa,M.","year":"2017","unstructured":"Balbaa,M.; Abdulmalek,SA.; Khalil,S. Oxidative stress and expres-sion of insulin signaling proteins in the brain of diabetic rats: role of Nigella sativa oil and antidiabetic drugs. PLoS One. 2017; 12(5): e0172429. http:\/\/dx.doi.org\/10.1371\/journal.pone.0172429 PMID: 28505155","journal-title":"PLoS One"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0197-4580(99) 00110-4","volume":"21(2)","author":"Breteler,MM","year":"2000","unstructured":"Breteler MM. Vascular risk fact ors for Alzheimer\u2019s disease: an epidemiologic perspective. Neurobiol Aging. 2000; 21(2): 153-60. http:\/\/dx.doi.org\/10.1016\/S0197-4580(99) 00110-4 PMID: 10867200","journal-title":"Neurobiol Aging"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2337\/db09-1163","volume":"59(3)","author":"Marioni,RE.","year":"2010","unstructured":"Marioni RE, Strachan MWJ, Reynolds RM.;et al. Association between raised inflammatory markers and cognitive decline in el-derly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes. 2010; 59(3): 710-3. http:\/\/dx.doi.org\/10.2337\/db09-1163 PMID: 19959761","journal-title":"Diabetes"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/s1980-6574201700si0008","volume":"23","author":"Kuga,GK.","year":"2017","unstructured":"Kuga,GK.; Botezelli,JD.; Gaspar,RC.; Gomes,RJ.; Pauli,JR.; De Al-meida Leme,JAC. Hippocampal insulin signaling and neuroprotec-tion mediated by physical exercise in Alzheimer\u2019s disease. Motriz Rev Educ Fis. 2017; 23: 1-6. http:\/\/dx.doi.org\/10.1590\/s1980-6574201700si0008","journal-title":"Motriz Rev Educ Fis"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","volume":"1863(5)","author":"Kandimalla,R.","year":"2017","unstructured":"Kandimalla,R.; Thirumala,V.; Reddy,PH.; States,U.; Texas,N. Is Alzheimer\u2019s disease a type 3 diab etes? A critical appraisal. Bio-chim Biophys Acta Mol Basis Dis. 2017; 1863(5): 1078-89. http:\/\/dx.doi.org\/10.1016\/j.bbadis.2016.08.018 PMID: 27567931","journal-title":"Bio-chim Biophys Acta Mol Basis Dis"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"456","DOI":"10.4239\/wjd.v6.i3.456","volume":"6(3)","author":"Tangvarasittichai,S","year":"2015","unstructured":"Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes. 2015; 6(3): 456-80. http:\/\/dx.doi.org\/10.4239\/wjd.v6.i3.456 PMID: 25897356","journal-title":"World J Diabetes"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/157015909787602823","volume":"7(1)","author":"Uttara,B.","year":"2009","unstructured":"Uttara,B.; Singh,AV.; Zamboni,P.; Mahajan,RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009; 7(1): 65-74. http:\/\/dx.doi.org\/10.2174\/157015909787602823 PMID: 19721819","journal-title":"Curr Neuropharmacol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","volume":"1842(8)","author":"Wang,X.","year":"2014","unstructured":"Wang,X.; Wang,W.; Li,L.; Perry,G.; Lee,HG.; Zhu,X. Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease. Biochim Biophys Acta. 2014; 1842(8): 1240-7. http:\/\/dx.doi.org\/10.1016\/j.bbadis.2013.10.015 PMID: 24189435","journal-title":"Biochim Biophys Acta"},{"key":"ref=58","doi-asserted-by":"publisher","author":"Mule,NK.","unstructured":"Mule,NK.; Singh,JN. Diabetes mellitus to neurodegenerative disor-ders: Is oxidative stress fueling the flame? CNS Neurol Disord Drug Targets. 2018; 17(9): 644-53. http:\/\/dx.doi.org\/10.2174\/1871527317666180809092359 PMID: 30091419","DOI":"10.2174\/1871527317666180809092359"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"e71304","DOI":"10.1371\/journal.pone.0071304","volume":"8(8)","author":"Lyoo,IK.","year":"2013","unstructured":"Lyoo IK, Yoon S, Renshaw PF.;et al. Network-level structural abnormalities of cerebral cortex in type 1 diabetes mellitus. PLoS One. 2013; 8(8): e71304. http:\/\/dx.doi.org\/10.1371\/journal.pone.0071304 PMID: 24058401","journal-title":"PLoS One"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"E468","DOI":"10.1210\/jc.2010-0744","volume":"95(12)","author":"Krug,R.","year":"2010","unstructured":"Krug,R.; Benedict,C.; Born,J.; Hallschmid,M. Comparable sensitivity of postmenopausal and young women to the effects of intranasal insulin on food intake and working memory. J Clin Endocrinol Metab. 2010; 95(12): E468-72. http:\/\/dx.doi.org\/10.1210\/jc.2010-0744 PMID: 20719831","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1210\/jc.2007-2606","volume":"93(4)","author":"Benedict,C.","year":"2008","unstructured":"Benedict,C.; Kern,W.; Schultes,B.; Born,J.; Hallschmid,M. Differen-tial sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J Clin Endocrinol Metab. 2008; 93(4): 1339-44. http:\/\/dx.doi.org\/10.1210\/jc.2007-2606 PMID: 18230654","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/j.1471-4159.2005.03269.x","volume":"94(4)","author":"van,der Heide,LP.","year":"2005","unstructured":"van,der Heide,LP.; Kamal,A.; Artola,A.; Gispen,WH.; Ramakers,GMJ. Insulin modulates hippocampa l activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner. J Neurochem. 2005; 94(4): 1158-66. http:\/\/dx.doi.org\/10.1111\/j.1471-4159.2005.03269.x PMID: 16092951","journal-title":"J Neurochem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0306-4530(02) 00087-2","volume":"28","author":"Craft,S.","year":"2003","unstructured":"Craft S, Asthana S, Cook DG, Baker LD, Cherrier M, Purganan K.;et al. Insulin dose \u2013 response effects on memory and plasma amy-loid precursor protein in Alzheimer\u2019s disease: interactions with apolipoprotein E genotype. Ps ychoneuroendocrinology. 2003; 28: 809-22. http:\/\/dx.doi.org\/10.1016\/S0306-4530(02) 00087-2","journal-title":"Ps ychoneuroendocrinology"},{"key":"ref=64","author":"Hanson,LR. .","unstructured":"Hanson,LR.; Frey,WH,II. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous sys-tem and treat neurodegenerative disease. BMC Neurosci. 2008; 9(Suppl","journal-title":"BMC Neurosci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1007\/s11095-012-0915-1","volume":"30(10)","author":"Chapman,CD.","year":"2013","unstructured":"Chapman CD, Frey WH II, Craft S.;et al. Intranasal treatment of central nervous system dysfunction in humans. Pharm Res. 2013; 30(10): 2475-84. http:\/\/dx.doi.org\/10.1007\/s11095-012-0915-1 PMID: 23135822","journal-title":"Pharm Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s40263-013-0076-8","volume":"27(7)","author":"Freiherr,J.","year":"2013","unstructured":"Freiherr J, Hallschmid M, Frey WH II.;et al. Intranasal insulin as a treatment for Alzheimer\u2019s disease: a review of basic research and clinical evidence. CNS Drugs. 2013; 27(7): 505-14. http:\/\/dx.doi.org\/10.1007\/s40263-013-0076-8 PMID: 23719722","journal-title":"CNS Drugs"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3233\/JAD-2009-1165","volume":"18(3)","author":"Watson,GS.","year":"2009","unstructured":"Watson GS, Baker LD, Cholerton BA.;et al. Effects of insulin and octreotide on memory and growth hormone in Alzheimer\u2019s disease. J Alzheimers Dis. 2009; 18(3): 595-602. http:\/\/dx.doi.org\/10.3233\/JAD-2009-1165 PMID: 19625744","journal-title":"J Alzheimers Dis"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1210\/jc.2011-1802","volume":"97(2)","author":"Shemesh,E.","year":"2012","unstructured":"Shemesh,E.; Rudich,A.; Harman-Boehm,I.; Cukierman-Yaffe,T. Effect of intranasal insulin on cognitive function: a systematic re-view. J Clin Endocrinol Metab. 2012; 97(2): 366-76. http:\/\/dx.doi.org\/10.1210\/jc.2011-1802 PMID: 22162476","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1212\/WNL.0b013e318245d295","volume":"78(6)","author":"Rodrigue,KM.","year":"2012","unstructured":"Rodrigue KM, Kennedy KM, Devous MD Sr.;et al. \u00df-Amyloid burden in healthy aging: regional distribution and cognitive conse-quences. Neurology. 2012; 78(6): 387-95. http:\/\/dx.doi.org\/10.1212\/WNL.0b013e318245d295 PMID: 22302550","journal-title":"Neurology"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1194\/jlr.M800402-JLR200","volume":"50(5)","author":"Scazzocchio,B.","year":"2009","unstructured":"Scazzocchio B, Var\u00ec R, D\u2019Archivio M.;et al. Oxidized LDL impair adipocyte response to insulin by activating serine\/threonine kinas-es. J Lipid Res. 2009; 50(5): 832-45. http:\/\/dx.doi.org\/10.1194\/jlr.M800402-JLR200 PMID: 19136667","journal-title":"J Lipid Res"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1210\/jc.2009-1677","volume":"95(2)","author":"Guthoff,M.","year":"2010","unstructured":"Guthoff M, Grichisch Y, Canova C.;et al. Insulin modulates food-related activity in the central nervous system. J Clin Endocrinol Metab. 2010; 95(2): 748-55. http:\/\/dx.doi.org\/10.1210\/jc.2009-1677 PMID: 19996309","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1017\/S1461145711001611","volume":"15(1)","author":"Moon,JH.","year":"2012","unstructured":"Moon JH, Kim HJ, Yang AH.;et al. The effect of rosiglitazone on LRP1 expression and amyloid \u00df uptake in human brain microvas-cular endothelial cells: a possible role of a low-dose thiazolidinedi-one for dementia treatment. Int J Neuropsychopharmacol. 2012; 15(1): 135-42. http:\/\/dx.doi.org\/10.1017\/S1461145711001611 PMID: 22040807","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/npp.2010.32","volume":"35(7)","author":"Escribano,L.","year":"2010","unstructured":"Escribano L, Sim\u00f3n AM, Gimeno E.;et al. Rosiglitazone rescues memory impairment in Alzheimer\u2019s transgenic mice: mechanisms involving a reduced amyloid and tau pathology. Neuropsycho-pharmacology. 2010; 35(7): 1593-604. http:\/\/dx.doi.org\/10.1038\/npp.2010.32 PMID: 20336061","journal-title":"Neuropsycho-pharmacology"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.nurt.2008.05.003","volume":"5(3)","author":"Landreth,G.","year":"2008","unstructured":"Landreth,G.; Jiang,Q.; Mandreka,r,S.; Heneka,M. PPARgamma ago-nists as therapeutics for the treatment of Alzheimer\u2019s disease. Neu-rotherapeutics. 2008; 5(3): 481-9. http:\/\/dx.doi.org\/10.1016\/j.nurt.2008.05.003 PMID: 18625459","journal-title":"Neu-rotherapeutics"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000318845","volume":"30(2)","author":"Gold,M.","year":"2010","unstructured":"Gold M, Alderton C, Zvartau-Hind M.;et al. Rosiglitazone mono-therapy in mild-to-moderate Alzheimer\u2019s disease: results from a randomized, double-blind, placebo-controlled phase III study. De-ment Geriatr Cogn Disord. 2010; 30(2): 131-46. http:\/\/dx.doi.org\/10.1159\/000318845 PMID: 20733306","journal-title":"De-ment Geriatr Cogn Disord"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijcard.2009.01.064","volume":"143(2)","author":"Mannucci,E.","year":"2010","unstructured":"Mannucci E, Monami M, Di Bari M.;et al. Cardiac safety profile of rosiglitazone: a comprehensive meta-analysis of randomized clini-cal trials. Int J Cardiol. 2010; 143(2): 135-40. http:\/\/dx.doi.org\/10.1016\/j.ijcard.2009.01.064 PMID: 19328563","journal-title":"Int J Cardiol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"369417","DOI":"10.1155\/2012\/369417","volume":"2012","author":"Babaei,P.","year":"2012","unstructured":"Babaei,P.; Soltani Tehrani,B.; A,lizadeh,A. Transplanted bone mar-row mesenchymal stem cells improve memory in rat models of Alzheimer\u2019s disease. Stem Cells Int. 2012; 2012: 369417. http:\/\/dx.doi.org\/10.1155\/2012\/369417 PMID: 22754576","journal-title":"Stem Cells Int"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2217\/rme.10.72","volume":"5(6)","author":"Joyce,N.","year":"2010","unstructured":"Joyce,N.; Annett,G.; Wirthlin,L.; Olson,S.; Bauer,G.; Nolta,JA. Mes-enchymal stem cells for the treatment of neurodegenerative disease. Regen Med. 2010; 5(6): 933-46. http:\/\/dx.doi.org\/10.2217\/rme.10.72 PMID: 21082892","journal-title":"Regen Med"},{"key":"ref=79","doi-asserted-by":"publisher","DOI":"10.2174\/1871527317666180627122448","author":"Singh,A.","unstructured":"Singh,A.; Hasan,A.; Tiwari,S.; Pandey,LM. Therapeutic advance-ment in Alzheimer disease: new hopes on the horizon? CNS Neurol Disord Drug Targets. 2018; 17(8): 571-89. http:\/\/dx.doi.org\/10.2174\/1871527317666180627122448 PMID: 29952273","journal-title":"2018; 17(8): 571-89"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1089\/wound.2011.0322","volume":"1(5)","author":"Layliev,J.","year":"2012","unstructured":"Layliev,J.; Wilson,S.; Warren,SM.; Saadeh,PB. Improving wound healing with topical gene therapy. Adv Wound Care (New Ro-chelle). 2012; 1(5): 218-23. http:\/\/dx.doi.org\/10.1089\/wound.2011.0322 PMID: 24527309","journal-title":"Adv Wound Care (New Ro-chelle)"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fcell.2014.00016","volume":"2","author":"Ikehara,S.","year":"2014","unstructured":"Ikehara,S.; Li,M. Stem cell transplantation improves aging-related diseases. Front Cell Dev Biol. 2014; 2: 16. http:\/\/dx.doi.org\/10.3389\/fcell.2014.00016 PMID: 25364723","journal-title":"Front Cell Dev Biol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"26417","DOI":"10.3390\/ijms161125961","volume":"16(11)","author":"Amemori,T.","year":"2015","unstructured":"Amemori,T.; Jendelova,P.; Ruzicka,J.; Urdzikova,LM.; Sykova,E. Alzheimer\u2019s disease: Mechanism and approach to cell therapy. Int J Mol Sci. 2015; 16(11): 26417-51. http:\/\/dx.doi.org\/10.3390\/ijms161125961 PMID: 26556341","journal-title":"Int J Mol Sci"},{"key":"ref=83","author":"Poduslo,JF.","unstructured":"Poduslo,JF.; Curran,GL.; Berg,CT. Macromolecular permeability across the blood-nerve and blood-brain barriers. Proc Natl Acad Sci USA 1994; 91(12): 5705-9. http:\/\/dx.doi.org\/10.1073\/pnas.91.12.5705 PMID: 8202551.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/jnnp.74.1.113","volume":"74(1)","author":"Rinne,JO.","year":"2003","unstructured":"Rinne JO, Kaasinen V, J\u00e4rvenp\u00e4\u00e4 T.;et al. Brain acetylcholinester-ase activity in mild cognitive impairment and early Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2003; 74(1): 113-5. http:\/\/dx.doi.org\/10.1136\/jnnp.74.1.113 PMID: 12486280","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"e37555","DOI":"10.1371\/journal.pone.0037555","volume":"7(5)","author":"Capsoni,S.","year":"2012","unstructured":"Capsoni S, Marinelli S, Ceci M.;et al. Intranasal \u201cpainless\u201d human nerve growth factor [corrected] slows amyloid neurodegeneration and prevents memory deficits in App X PS1 mice. PLoS One. 2012; 7(5): e37555. http:\/\/dx.doi.org\/10.1371\/journal.pone.0037555 PMID: 22666365","journal-title":"PLoS One"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1586\/14737175.8.11.1703","volume":"8(11)","author":"Mufson,EJ.","year":"2008","unstructured":"Mufson,EJ.; Counts,SE.; Perez,SE.; Ginsberg,SD. Cholinergic sys-tem during the progression of Alzheimer\u2019s disease: therapeutic im-plications. Expert Rev Neurother. 2008; 8(11): 1703-18. http:\/\/dx.doi.org\/10.1586\/14737175.8.11.1703 PMID: 18986241","journal-title":"Expert Rev Neurother"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/182076","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/182076\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/182076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T19:25:37Z","timestamp":1615577137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/182076\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8,17]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527319666200518102130","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,17]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}